Wound Debridement Market by Product (Enzymatic, Autolytic (Gels, Ointments), Mechanical (Medical Gauzes), Surgical, Ultrasonic), Wound Type (Diabetic Foot Ulcers, Venous Leg, Pressure Ulcers, Burns), End User (Hospitals, Clinics) - Global Forecast to 2025" The wound debridement market is projected to reach a value of USD 1,162 million by 2025 from USD 822 million in 2020, at a CAGR of 7.2% from 2020 to 2025. The high incidence of diabetes and other target diseases, the availability of reimbursement for wound debridement in developed economies, and the increasing number of burn cases are driving the growth of the wound debridement market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21606123

Browse in-depth TOC on "Wound Debridement Market”

115 – Tables

32 – Figures

131 – Pages

Key Player

The wound debridement market is consolidated in nature. In 2019, Smith Nephew (UK), B. Braun Melsungen AG (Germany), Coloplast (Denmark), ConvaTec (UK), Mölnlycke Healthcare (Sweden), Lohmann Rauscher (Germany), Integra Lifesciences (US), Zimmer Biomet (US), Misonix (US), and Paul Hartmann AG (Germany) were the leading players.

Smith Nephew offers a wide range of products in the wound debridement market, such as surgical devices, gels, and ointments. Due to its well-established product portfolio and good brand image, the company is able to maintain its leading position in the wound debridement market. In addition to this, the company has a direct presence in more than 100 countries across the globe. Moreover, the company has well-established distribution channels in developed markets such as the US. It generated ~50% of its revenue from the US alone in 2019.

B. Braun offers a wide range of gel products and pads for wound debridement. The company has a strong presence and well-established distribution channels across Europe, North America, and the APAC. Moreover, it has a good brand image in the wound care segment. All these factors have enabled it to become the second-largest player in the wound debridement market. In the coming years, the company can maintain its market leadership if it focuses on ointments, gauzes, and surgical instruments.

Ultrasonic debridement products segment to witness the highest growth during the forecast period

Based on product, the wound debridement market is categorized into enzymatic, autolytic, mechanical, surgical, ultrasonic, and others. The ultrasonic debridement products segment is expected to grow at the highest growth rate during the forecast period. This is primarily attributed to factors such as their high efficacy in debriding and precision (lack of damage to healthy tissue) during debridement.

Inquiry Before Buying @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=21606123

Hospitals accounted for the largest share of the wound debridement market, by end user

Based on end user, the market has been segmented into hospitals, clinics, and other end users. In 2019, the hospitals segment accounted for the largest market share. The availability of infrastructure and the presence of skilled professionals in hospitals are the major driving factors for this segment.

North America is the largest regional market for wound debridement

The wound debridement market, by region, has been segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW). North America is the largest market for wound debridement, followed by Europe. Growth in the North American market can be attributed to the increasing prevalence of diabetes, high penetration of enzymatic debridement products, and strong market player presence. However, the Asia Pacific market is expected to register the highest CAGR during the forecast period. Growth in this region is driven by the presence of a large patient population and increasing awareness regarding advanced healthcare products.

Recent Developments:

• In April 2019, RLS Global (Sweden) received CE approval for ChloraSolv
• In July 2017, Smith amp; Nephew (UK) opened a new RD centre in Hull, UK

View detailed Table of Content here@ https://www.marketsandmarkets.com/Market-Reports/wound-debridement-market-21606123.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: [email protected]

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-culture-market.asp

Visit Our Website: https://www.marketsandmarkets.com/

Content Source: https://www.marketsandmarkets.com/PressReleases/wound-debridement.asp